Next Generation Sequencing Reveals Pathogenic and Actionable Genetic Alterations of Soft Tissue Sarcoma in Chinese Patients: A Single Center Experience
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 20
Abstract
Background: Next generation sequencing (NGS) has systematically investigated the genomic landscape of soft tissue sarcoma (STS) in Western patients, but few reports have described the utility of NGS in identifying pathogenic and targetable mutations in Asian patients. Methods: We review our single center experience of identifying the genomic profile and feasible genetic mutations in 65 Chinese patients with STS by NGS. Results: On average, 3.35 mutations were identified per patient (range, 0-28), and at least one mutation could be detected in 95.4% (62/65) of patients. TP53, MDM2, CDK4, KDR, and NF1 were the most frequent mutation genes in Chinese STS patients. Actionable mutations were discovered in 36.9% (24/65) of patients, and clinical benefit was achieved in 4 patients treated with corresponding molecular targeted therapies. Conclusions: Our study describes the mutation profile of Chinese STS patients by a single center experience. Some patients have achieved improved clinical outcomes by adopting treatment based on the results of genetic testing. NGS may affect clinical decision-making as a routine clinical test for patients with STS.Keywords
This publication has 30 references indexed in Scilit:
- Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid TumorsJAMA Oncology, 2016
- Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeuticsHuman Pathology, 2014
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trialThe Lancet Oncology, 2014
- WHO classification of soft tissue tumours: an update based on the 2013 (4th) editionPathology, 2014
- Mutational heterogeneity in cancer and the search for new cancer-associated genesNature, 2013
- Histologic and Genetic Advances in Refining the Diagnosis of “Undifferentiated Pleomorphic Sarcoma”Cancers, 2013
- Soft Tissue SarcomasCA: A Cancer Journal for Clinicians, 2004
- Current soft-tissue sarcoma classificationsEuropean Journal of Cancer, 2004
- Prognostic factors in soft tissue sarcomas: a study of 395 patientsEuropean Journal of Surgical Oncology, 2002
- Outcome and prognostic factors in soft tissue sarcoma in the adultInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993